We should look forward to a safe, effective vaccine for coronavirus disease 2019 (COVID-19) but not expect it to be the ultimate panacea.
Sarfaraz K. Niazi, PhD
Advertisement
Sarfaraz K. Niazi, PhD, is an adjunct professor of biopharmaceutical sciences at the University of Illinois, and founder of biosimilars companies Karyo Biologics and Adello Biologics. He also founded the biosimilar advisory company PharmSci.
Articles by Sarfaraz K. Niazi, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
